Clearside Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CLSD and buy or sell other stocks, ETFs, and their options commission-free!About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases.
CEOGeorge M. Lasezkay, PharmD
CEOGeorge M. Lasezkay, PharmD
Employees32
Employees32
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded2011
Founded2011
Employees32
Employees32
CLSD Key Statistics
Market cap3.93M
Market cap3.93M
Price-Earnings ratio-0.15
Price-Earnings ratio-0.15
Dividend yield—
Dividend yield—
Average volume12.82K
Average volume12.82K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$17.10
52 Week high$17.10
52 Week low$0.31
52 Week low$0.31
Stock Snapshot
Clearside Biomedical(CLSD) stock is priced at $0.75, giving the company a market capitalization of 3.93M. It carries a P/E multiple of -0.15.
During the trading day, Clearside Biomedical(CLSD) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 12.82K.
The stock's 52-week range extends from a low of $0.31 to a high of $17.10.
The stock's 52-week range extends from a low of $0.31 to a high of $17.10.
People also own
Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.